A pooled prime editing platform in haploid human cells for high-throughput variant screening

Michael Herger is a biologist with a special interest in interrogating the function, interactions, and mechanisms of epigenetic factors using scalable functional genomics tools. Currently, he is a postdoctoral fellow in Greg Findlay’s Lab at the Francis Crick Institute (London, UK) and previously earned his PhD at the University of Cambridge, focusing on directed evolution of CRISPR/Cas reagents. He will be co-presenting recent work on pooled prime editing screens in human haploid cells together with Christina Kajba.